Elicio Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 1.69 USD (Oct 30, 2026, 3:05 PM EDT) · Market cap 44.42M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node-targeted AMP peptide treatment for mutant b-raf murine sarcoma viral oncogene homolog B1-(BRAF) driven cancers, and ELI-008, a multivalent lymph node-targeted AMP peptide vaccine in preclinical studies for the treatment of mutated tumor protein p53-expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Details
| Name | Elicio Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 33 |
| Founded | 2011 |
| Ceo | Robert Connelly |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 0.00 |
| Isin | US28657F1030 |
| Cusip | 28657F103 |
| Cik | 0001601485 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Robert T. Connelly | Chief Executive Officer, President and Director |
| Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D. | Founder and Independent Director |
| Dr. Preetam Shah M.B.A., Ph.D. | Chief Strategy and Financial Officer and Treasurer |
| Dr. Christopher M. Haqq M.D., Ph.D. | Executive Vice President, Head of Research and Development and Chief Medical Officer |
| Dr. Darrell J. Irvine Ph.D. | Co-Founder, Consultant, Board Observer and Chairman of Scientific Advisory Board |
| Marc J. Wolfgang M.S. | Chief Technology Officer |
| Dr. Peter DeMuth Ph.D. | Chief Scientific Officer |
| Megan C. Filoon | General Counsel, Secretary and Compliance Officer |
| Esther Welkowsky | Senior Vice President of Clinical Development |
| Joy Seymour | Senior Vice President and Head of Regulatory Affairs |
Contact
| Address | 451 D Street, 5th Floor, Boston, Massachusetts 02210, United States |
| Phone | 857 209 0050 |
| Website | https://elicio.com |